Case Disclosed

The U.S. Supreme Court ruled that the manner in which a New York law prohibits merchants from imposing credit card surcharges amounts to a regulation of their speech.

President Trump has signaled—often and recently—that he believes drug approval moves too slowly. Meeting with drug manufacturers at the White House on Jan. 31, Trump promised quick yes-or-no approval decisions on new drugs (and stressed the need for lower prices and U.S.-based manufacturing). But the FDA moves fast already— fast enough, say some experts who worry about the standards used to move drugs through review pathways like Priority Review, Breakthrough Therapy, Accelerated Approval, and Fast Track. And when the president pushes for even less rigor, these questions become even more

Canada’s public health department, Health Canada, is preparing to release its final guidance on the section of Vanessa’s Law designed to promote the transparency of information around pharmaceutical drugs.